Alimentary Pharmacology and Therapeutics
- Print ISSN
- Electronic ISSN
- Impact factor
- Usage rank
- Article count
- Free count
- Free percentage
- PDFs via platforms
- Ebscoatoz, CSA, Ovid from 2000, Ebsconet, Wiley from 1987, Ebsco, Gale, and Proquest
Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease.
Treatments for Crohn's disease (CD) and ulcerative colitis (UC) are not uniformly effective, thus necessitating dose changes, switching, and augmentation and carry adverse event risk, often requiring discontinuation, which reduces treatment benefits. To assess continuity of and changes to initial CD...
Commentary: scoring models for short-term mortality in alcoholic hepatitis.
Letter: nonresponsive coeliac disease and evaluation of the strictness of a gluten-free diet.
Commentary: dissecting the PNPLA3 association with liver fat and stiffness, and interaction with diet.
Letter: diverticulosis in inflammatory bowel diseases.
Letter: effects of oxycodone and tapentadol dosage on gastrointestinal function - author's reply.
Letter: anti-TNFs and psoriasis - friends or foes? Authors' reply.
The Fatigue Questionnaire has a good test-retest profile in IBD.
Anti-TNF associated psoriasis.
Microscopic colitis and disease associations: authors' reply.